APA (7th ed.) Citation

Baum, M. A., Langman, C., Cochat, P., Lieske, J. C., Moochhala, S. H., Hamamoto, S., . . . Hoppe, B. (2023). PHYOX2: A pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2. Kidney international, 103(1), . https://doi.org/10.1016/j.kint.2022.07.025

Chicago Style (17th ed.) Citation

Baum, Michelle A., et al. "PHYOX2: A Pivotal Randomized Study of Nedosiran in Primary Hyperoxaluria Type 1 or 2." Kidney International 103, no. 1 (2023). https://doi.org/10.1016/j.kint.2022.07.025.

MLA (9th ed.) Citation

Baum, Michelle A., et al. "PHYOX2: A Pivotal Randomized Study of Nedosiran in Primary Hyperoxaluria Type 1 or 2." Kidney International, vol. 103, no. 1, 2023, https://doi.org/10.1016/j.kint.2022.07.025.